Biotechnology Innovation Organization· @IAmBiotech · X·· 26 天前AI 评分27
AI 导读
各州立法机构结束了2026年会期，在处方药可负担性委员会、340B监管、疫苗责任和AI监管方面持续有所动作。http://Bio.News 与BIO的Patrick Plues聊了他进入2027年关注的重点： https://bio.news/state-policy/mid-year-review-state-level-legislative-action-impacting-biotech/
正文
State legislatures wrapped their 2026 sessions with continued activity on prescription drug affordability boards, 340B oversight, vaccine liability, and AI regulation. http://Bio.News chatted with BIO's Patrick Plues on what he's tracking heading into 2027: https://bio.news/state-policy/mid-year-review-state-level-legislative-action-impacting-biotech/
来源：Biotechnology Innovation Organization · x.com